Cancer risk in hospitalized sarcoidosis patients: A follow-up study in Sweden

Annals of Oncology

Volumn 20, Issue 6, 2009, Pages 1121-1126

  Ji, Jianguang ^a   Shu, X ^a   Li, X ^a   Sundquist, K ^a   Sundquist, J ^b   Hemminki, K ^a,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Cancer; National databases; Sarcoidosis

Indexed keywords

ARTICLE; CANCER INCIDENCE; CANCER RISK; CONTROLLED STUDY; ENDOCRINE TUMOR; FOLLOW UP; HIGH RISK PATIENT; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; KIDNEY TUMOR; LEUKEMIA; MAJOR CLINICAL STUDY; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; SARCOIDOSIS; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; STANDARDIZED INCIDENCE RATIO; SWEDEN; TREND STUDY;

FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; NEOPLASMS; RISK ASSESSMENT; SARCOIDOSIS; SWEDEN;

EID: 66149146272     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdn767     Document Type: Article

References (26)

1. Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med 2007; 357: 2153-2165.
2. Baughman RP, Lower EE, du Bois RM. Sarcoidosis. Lancet 2003; 361: 1111-1118.
3. Milman N, Selroos O. Pulmonary sarcoidosis in the Nordic countries 1950-1982. Epidemiology and clinical picture. Sarcoidosis 1990; 7: 50-57.
4. Henke CE, Henke G, Elveback LR et al. The epidemiology of sarcoidosis in Rochester, Minnesota: A population-based study of incidence and survival. Am J Epidemiol 1986; 123: 840-845.
5. McGrath DS, Daniil Z, Foley P et al. Epidemiology of familial sarcoidosis in the UK. Thorax 2000; 55: 751-754.
6. Rybicki BA, Iannuzzi MC, Frederick MM et al. Familial aggregation of sarcoidosis. A case-control etiologic study of sarcoidosis (ACCESS). Am J Respir Crit Care Med 2001; 164: 2085-2091.
7. Schurmann M, Lympany PA, Reichel P et al. Familial sarcoidosis is linked to the major histocompatibility complex region. Am J Respir Crit Care Med 2000; 162: 861-864.
8. Grutters JC, Sato H, Pantelidis P et al. Increased frequency of the uncommon tumor necrosis factor - 2857T allele in British and Dutch patients with sarcoidosis. Am J Respir Crit Care Med 2002; 165: 1119-1124.
9. Yamaguchi E, Itoh A, Hizawa N, Kawakami Y. The gene polymorphism of tumor necrosis factor-beta, but not that of tumor necrosis factor-alpha, is associated with the prognosis of sarcoidosis. Chest 2001; 119: 753-761.
10. Kettritz R, Goebel U, Fiebeler A et al. The protean face of sarcoidosis revisited. Nephrol Dial Transplant 2006; 21: 2690-2694.
11. Askling J, Grunewald J, Eklund A et al. Increased risk for cancer following sarcoidosis. Am J Respir Crit Care Med 1999; 160: 1668-1672.
12. Brincker H, Wilbek E. The incidence of malignant tumours in patients with respiratory sarcoidosis. Br J Cancer 1974; 29: 247-251.
13. Romer FK, Hommelgaard P, Schou G. Sarcoidosis and cancer revisited: A longterm follow-up study of 555 Danish sarcoidosis patients. Eur Respir J 1998; 12: 906-912.
14. Le Jeune I, Gribbin J, West J et al. The incidence of cancer in patients with idiopathic pulmonary fibrosis and sarcoidosis in the UK. Respir Med 2007; 101: 2534-2540.
15. Sharma OP, Lamb C. Cancer in interstitial pulmonary fibrosis and sarcoidosis. Curr Opin Pulm Med 2003; 9: 398-401.
16. Hemminki K, Li X, Sundquist K, Sundquist J. Cancer risk in hospitalized rheumatoid arthritis patients. Rheumatology (Oxford) 2008; 47: 698-701.
17. Soderberg KC, Jonsson F, Winqvist O et al. Autoimmune diseases, asthma and risk of haematological malignancies: A nationwide case-control study in Sweden. Eur J Cancer 2006; 42: 3028-3033.
18. Boffetta P, Gridley G, Lindelof B. Cancer risk in a population-based cohort of patients hospitalized for psoriasis in Sweden. J Invest Dermatol 2001; 117: 1531-1537.
19. Esteve J, Benhamou E, Raymond L. Statistical Methods in Cancer Research. Lyon, France: IARC 1994.
20. Brincker H. Sarcoid reactions and sarcoidosis in Hodgkin's disease and other malignant lymphomata. Br J Cancer 1972; 26: 120-123.
21. Seersholm N, Vestbo J, Viskum K. Risk of malignant neoplasms in patients with pulmonary sarcoidosis. Thorax 1997; 52: 892-894.
22. Brincker H. The sarcoidosis-lymphoma syndrome. Br J Cancer 1986; 54: 467-473.
23. Romero J, Ramon y Cajal S, Vargas JA et al. Association of sarcoidosis, low-grade B-lymphoma and epidermoid carcinoma. Postgrad Med J 1997; 73: 580-582.
24. Miyara M, Amoura Z, Parizot C et al. The immune paradox of sarcoidosis and regulatory T cells. J Exp Med 2006; 203: 359-370.
25. Valeyre D, Soler P, Clerici C et al. Smoking and pulmonary sarcoidosis: effect of cigarette smoking on prevalence, clinical manifestations, alveolitis, and evolution of the disease. Thorax 1988; 43: 516-524.
26. Douglas JG, Middleton WG, Gaddie J et al. Sarcoidosis: A disorder commoner in non-smokers? Thorax 1986; 41: 787-791.